dc.contributor.author | Vasiljević, N | |
dc.contributor.author | Carter, PD | |
dc.contributor.author | Reuter, C | |
dc.contributor.author | Warman, R | |
dc.contributor.author | Brentnall, AR | |
dc.contributor.author | Carton, JR | |
dc.contributor.author | Cuzick, J | |
dc.contributor.author | Lorincz, AT | |
dc.date.accessioned | 2018-02-19T16:31:14Z | |
dc.date.issued | 2017-08-15 | |
dc.identifier.citation | International Journal of Cancer, 2017, 141 (4), pp. 829 - 836 | |
dc.identifier.issn | 0020-7136 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/1324 | |
dc.identifier.doi | 10.1002/ijc.30783 | |
dc.format.extent | 829 - 836 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | Wiley | |
dc.title | Role of quantitative p16INK4A mRNA assay and digital reading of p16INK4A immunostained sections in diagnosis of cervical intraepithelial neoplasia | |
dc.type | Journal Article | |
rioxxterms.versionofrecord | 10.1002/ijc.30783 | |
rioxxterms.licenseref.startdate | 2017-08-15 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | International Journal of Cancer | |
pubs.issue | 4 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.publication-status | Published | |
pubs.volume | 141 | |
pubs.embargo.terms | Not known | |
dc.contributor.icrauthor | Marsden, | en |